Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity

Journal of Zhejiang University: Science B

Volumn 12, Issue 7, 2011, Pages 568-574

  Liang, Yun ^a   Qiu, Xi ^a   Xu, Rong Zhen ^a,b   Zhao, Xiao Ying ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; Berbamine; KU812 cells; Smad3

Indexed keywords

BERBAMINE; CYCLIN D2; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; MYC PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CYTOTOXICITY; DRUG MECHANISM; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IC 50; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; BENZYLISOQUINOLINES; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; G1 PHASE; GENE EXPRESSION REGULATION; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SMAD3 PROTEIN;

EID: 79960463530     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1000230     Document Type: Article

References (23)

1. X. An A.K. Tiwari Y. Sun P.R. Ding 2010 BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review Leuk. Res. 34 10 1255 1268 20537386 10.1016/j.leukres.2010. 04.016 1:CAS:528:DC%2BC3cXhtV2itLnO
2. A. Chaudhury P.H. Howe 2009 The tale of transforming growth factor-β (TGFβ) signaling: a soigné enigma IUBMB Life 61 10 929 939 19787707 10.1002/iub.239 1:CAS:528:DC%2BD1MXht1WntbbL
3. G.F. Claassen S.R. Hann 2000 A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor β-induced cell-cycle arrest PNAS 97 17 9498 9503 10920185 10.1073/pnas.150006697 1:CAS:528:DC%2BD3cXmtVensLo%3D (Pubitemid 30650804)
4. M. Dong G.C. Blobe 2006 Role of transforming growth factor-β in hematologic malignancies Blood 107 12 4589 4596 16484590 10.1182/blood-2005-10- 4169 1:CAS:528:DC%2BD28XlvFCgs7g%3D (Pubitemid 43882602)
5. B.J. Druker F. Guilhot S.G. O'Brien I. Gathmann H. Kantarjian N. Gattermann M.W. Deininger R.T. Silver J.M. Goldman R.M. Stone, et al. 2006 Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia N. Engl. J. Med. 355 23 2408 2417 17151364 10.1056/NEJMoa062867 1:CAS:528:DC%2BD28Xht12ntrzM (Pubitemid 44903745)
6. R.L. Elliott G.C. Blobe 2005 Role of transforming growth factor β in human cancer J. Clin. Oncol. 23 9 2078 2093 15774796 10.1200/JCO.2005.02.047 1:CAS:528:DC%2BD2MXjt1Cku7c%3D (Pubitemid 46211385)
7. J.A. Engelman J. Settleman 2008 Acquired resistance to tyrosine kinase inhibitors during cancer therapy Curr. Opin. Genet. Dev. 18 1 73 79 18325754 10.1016/j.gde.2008.01.004 1:CAS:528:DC%2BD1cXmsVartbc%3D (Pubitemid 351694445)
8. S.J. Kim J. Letterio 2003 Transforming growth factor-β signaling in normal and malignant hematopoiesis Leukemia 17 9 1731 1737 12970772 10.1038/sj.leu.2403069 1:CAS:528:DC%2BD3sXntFChsr4%3D (Pubitemid 37185248)
9. Y. Liang R.Z. Xu L. Zhang X.Y. Zhao 2009 Berbamine, a novel nuclear factor κB inhibitor, inhibits growth and induces apoptosis in human myeloma cells Acta Pharmacol. Sin. 30 12 1659 1665 19960011 10.1038/aps.2009.167 1:CAS:528:DC%2BD1MXhsFSqtL%2FF
10. K. Mitani 2004 Molecular mechanisms of leukemogenesis by AML1/EVI-1 Oncogene 23 24 4263 4269 15156182 10.1038/sj.onc.1207777 1:CAS:528: DC%2BD2cXkvVCht7o%3D (Pubitemid 38758593)
11. M. Ozaki N. Kanemitsu M. Yasukawa S. Fujita 1989 Basophilic crisis of chronic myelogenous leukemia Jpn J. Med. 28 1 67 71 2724649 1:STN:280: DyaL1M3lvFKrsw%3D%3D (Pubitemid 19117235)
12. K. Pardali M. Kowanetz C.H. Heldin A. Moustakas 2005 Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21(WAF1/Cip1) J. Cell. Physiol. 204 1 260 272 15690394 10.1002/jcp.20304 1:CAS:528:DC%2BD2MXkvF2qsLY%3D (Pubitemid 40776829)
13. B.W.M. Richter C.S. Duckett 2000 The IAP proteins: caspase inhibitors and beyond Sci. STKE 44 PE1
14. H.M. Rooke M.R. Vitas P.S. Crosier K.E. Crosier 1999 The TGF-β type II receptor in chronic myeloid leukemia: analysis of microsatellite regions and gene expression Leukemia 13 4 535 541 10214859 10.1038/sj.leu.2401384 1:CAS:528:DyaK1MXivFSktLs%3D (Pubitemid 29195281)
15. F.W. Ruscetti S. Akel S.H. Bartelmez 2005 Autocrine transforming growth factor-β regulation of hematopoiesis: many outcomes that depend on the context Oncogene 24 37 5751 5763 16123808 10.1038/sj.onc.1208921 1:CAS:528:DC%2BD2MXptVertLk%3D (Pubitemid 43086135)
16. M. Steinberg 2007 Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia Clin. Ther. 29 11 2289 2308 18158072 10.1016/j.clinthera.2007.11.005 1:CAS:528:DC%2BD1cXhtVKjt7k%3D
17. Y.L. Wei L. Xu Y. Liang X.H. Xu X.Y. Zhao 2009 Berbanine exhibits potent antitumor effects on imatinib-resistant CML cells in vitro and in vivo Acta Pharmacol. Sin. 30 4 451 457 19270722 10.1038/aps.2009.19 1:CAS:528: DC%2BD1MXjvF2htbs%3D
18. Y.L. Wei L. Xu X.Y. Zhao 2009 Mechanism related to inhibition of leukemia K562 cells by berbamine J. Zhejiang Univ. (Med. Sci.) 38 4 387 391 1:CAS:528:DC%2BD1MXhs1amsrvE
19. L.A. Wolfraim T.M. Fernandez M. Mamura W.L. Fuller R. Kumar D.E. Cole 2004 Loss of Smad3 in acute T-cell lymphoblastic leukemia N. Engl. J. Med. 351 6 552 559 15295048 10.1056/NEJMoa031197 1:CAS:528:DC%2BD2cXmtF2rur8%3D (Pubitemid 39025172)
20. R.Z. Xu Q.H. Dong Y.Z. Yu X.Y. Zhao X.X. Gan D. Wu Q.H. Lu X.H. Xu X.F. Yu 2006 Berbanine: a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity Leuk. Res. 30 1 17 23 16023722 10.1016/j.leukres.2005.05. 023 1:CAS:528:DC%2BD2MXht1GnsLzE (Pubitemid 41654699)
21. K. Yagi M. Furuhashi H. Aoki D. Goto H. Kuwano K. Sugamura K. Miyazono M. Mitsuyasu Kato 2002 C-Myc is a downstream target of the Smad pathway J. Biol. Chem. 277 1 854 861 11689553 10.1074/jbc.M104170200 1:CAS:528: DC%2BD38XjslGrsg%3D%3D (Pubitemid 34952127)
22. L. Zhang Z. Sun A.L. Shen L. Ma X.Y. Jiang G.J. Ma 2003 The effects of the Smad3-knockout on the hematopoiesis of mouse Chin. J. Biotechnol. 19 4 428 432 1:CAS:528:DC%2BD2cXhtVSlsLjJ
23. H.J. Zhu A.W. Burgess 2001 Regulation of transforming growth factor-β signaling Mol. Cell Biol. Res. Commun. 4 6 321 330 11703090 10.1006/mcbr.2001.0301 1:CAS:528:DC%2BD38XptVCg (Pubitemid 33098102)